Latigo Biotherapeutics

Latigo

This clinical-stage biopharmaceutical company develops non-opioid medicines to treat acute and chronic pain for patients needing alternatives to addictive painkillers.

Mimetic Medicines

This company develops non-opioid peptide drug candidates for patients suffering from chronic pain.

Epiodyne

This biotechnology company develops small-molecule opioid medicines for patients requiring pain management or treatment for opioid use disorder.

Neurosciences

This company develops precision sodium channel therapeutics to treat patients with neurological conditions such as genetic epilepsy and chronic neuropathic pain.

Centrexion

Centrexion develops non-opioid, non-addictive therapies for the treatment of chronic pain and autoimmune diseases for patients with unmet medical needs.

Saol Therapeutics

This pharmaceutical company develops clinical-stage therapies for patients with central nervous system disorders, pain, spasticity and orphan diseases.

PainReform

This pharmaceutical company develops extended-release anesthetic formulations to provide post-operative pain relief for surgical patients and reduce opioid dependency.

Brise Pharmaceuticals Co., LTD.

This biopharmaceutical company develops analgesic treatments for patients with severe pain conditions including migraine, neuropathic pain, and musculoskeletal pain.